dementia

(redirected from Dementia with Lewy bodies)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Dementia with Lewy bodies: vascular dementia, Frontotemporal dementia
References in periodicals archive ?
Alpha-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies.
Once the diagnosis of dementia with Lewy bodies is made, patients can use drugs that can treat cognitive issues, Dr.
Although it is possible that both of the diseases may lie on a continuum of a single disease that begins with ADHD manifested in childhood and continues into adulthood as dementia with Lewy bodies "when neuronal loss and gliosis in the substantia nigra, locus coeruleus, and nucleus basalis of Meynert occur," the authors doubted that this hypothesis could be accurate because low dopamine levels in ADHD are not initially associated with Parkinsonlike or DLB symptoms.
Suppression of progression of dementia symptoms in dementia of the Alzheimer's type and dementia with Lewy bodies.
If motor symptoms appear first, we call it Parkinson's disease, while if dementia is the initial symptom, we call it dementia with Lewy bodies.
The dementia patients comprised 109 people with dementia with Lewy bodies (DLB) and 251 with Alzheimer's.
PET imaging shows that patients with dementia with Lewy bodies (DLB) have slightly more [beta]-amyloid in the occipital and sensorimotor cortex than do patients with AD, a finding that may help physicians distinguish the two conditions with similar symptoms, according to a poster that was presented by Victor L.
In addition, a study published in The Lancet in 2000 also showed improvements to CDR attention measures when rivastigmine was administered to patients with Dementia with Lewy Bodies.
Clinical Features of Dementia Associated with Parkinson's Disease and Dementia with Lewy Bodies
Dementia with Lewy bodies is the third most common form of dementia and can have distressing symptoms including hallucinations, movement problems and fluctuations in attention.
Currently, the company is conducting two clinical development projects for Aricept in Japan with the aim of obtaining approval to use this medicine for the treatment of dementia with Lewy bodies (Phase III) as well as of a new higher dose 23 mg tablet (Phase II), and will endeavor to further enhance the value of this drug even beyond expiration of the drug's composition of matter patent.
Mayo Clinic scientists found identified 27 people who experienced rapid eye movement (REM) sleep behavior disorder for at least 15 years before developing one of three conditions: Parkinson's disease, dementia with Lewy bodies or multiple system atrophy.